Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 20

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 20
---
 could result in a loss of your entire investment. Further, the      
 issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in the registration statement,    
 of which this prospectus forms a part, at any given time could cause the market price of our common stock to decline and to be highly 
 volatile, and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior 
 to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you     
 should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 12.                                     |
| Trading                             
 Symbol on the Nasdaq Capital Market |     | LRHC                                                                                                                                  |

| (1) | Based on 58,317,932 shares of common stock outstanding as of June 23, 2025. Other                       
 than the shares of common stock underlying the Initial Note, it excludes the following as of such date: |

| ● | 3,814,757                                                                                    
 shares of our common stock issuable upon the exercise of warrants outstanding, at a weighted 
 average exercise price of $0.42 per share;                                                   |

| ● | 4,332,161                                                                                                                         
 shares of our common stock issuable upon the exercise of stock options outstanding, at a weighted average exercise price of $1.46 
 per share;                                                                                                                        |

| ● | 763,302                                                                             
 shares of our common stock issuable upon the vesting of restricted stock units; and |

| ● | 5,095,463                                                                                   
 shares of our common stock reserved for future issuance under our Amended and Restated 2022 
 Equity Incentive Plan.                                                                      |

<div align='center'>11

RISK FACTORS</div>

The risks and uncertainties described therein and below could materially adversely affect our business, operating results and financial condition, as well as cause the value of our securities to decline. You may lose all or part of your investment as a result. You should also refer to the other information contained in this prospectus, or incorporated by reference, including our financial statements and the notes to those statements, and the information set forth under the caption “Special Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks mentioned below. Forward-looking statements included in this prospectus are based on